Lowering cholesterol, 1988. Rationale, mechanisms, and means.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (63)
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 • 5,638 citations
The Pathogenesis of Atherosclerosis — An Update
1986 • 4,951 citations
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 • 3,889 citations
The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
1977 • 2,481 citations
Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
1979 • 2,458 citations
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
1988 • 2,276 citations
Apolipoprotein E polymorphism and atherosclerosis.
1988 • 2,007 citations
Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
1986 • 1,857 citations
Beneficial Effects of Combined Colestipol-Niacin Therapy on Coronary Atherosclerosis and Coronary Venous Bypass Grafts
1987 • 1,651 citations
Is Relationship Between Serum Cholesterol and Risk of Premature Death From Coronary Heart Disease Continuous and Graded?
1986 • 1,248 citations
Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
1987 • 1,051 citations
Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
1987 • 885 citations
Lowering Blood Cholesterol to Prevent Heart Disease
1985 • 667 citations
Probucol inhibits oxidative modification of low density lipoprotein.
1986 • 633 citations
Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding.
1987 • 476 citations
[1] Introduction to the plasma lipoproteins
1986 • 420 citations
Deletion in Cysteine-Rich Region of LDL Receptor Impedes Transport to Cell Surface in WHHL Rabbit
1986 • 335 citations
Hepatic catabolism of rat and human lipoproteins in rats treated with 17 alpha-ethinyl estradiol.
1979 • 322 citations
Dietary saturated triacylglycerols suppress hepatic low density lipoprotein receptor activity in the hamster.
1985 • 318 citations
Lipoproteins and atherosclerosis. A look back and a look ahead.
1983 • 315 citations
Effects of probucol on xanthomata regression in familial hypercholesterolemia
1986 • 232 citations
Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts
1987 • 231 citations
Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial Hypercholesterolemia
1987 • 215 citations
Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia.
1985 • 210 citations
Reduction of Serum Cholesterol in Heterozygous Patients with Familial Hypercholesterolemia
1983 • 201 citations
Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug Regimen
1981 • 197 citations
New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.
1987 • 196 citations
Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hypelipidaemic individuals
1987 • 166 citations
Therapeutic Response to Lovastatin (Mevinolin) in Nonfamilial Hypercholesterolemia
1986 • 160 citations
Total cholesterol and high density lipoprotein cholesterol levels in populations differing in fat and carbohydrate intake.
1987 • 150 citations
The long term effects of dietary cholesterol upon the plasma lipids, lipoproteins, cholesterol absorption, and the sterol balance in man: the demonstration of feedback inhibition of cholesterol biosynthesis and increased bile acid excretion
1980 • 148 citations
Mevinolin Plus Colestipol in Therapy for Severe Heterozygous Familial Hypercholesterolemia
1984 • 132 citations
Cholesterol Transport Between Cells and Body Fluids: Role of Plasma Lipoproteins and the Plasma Cholesterol Esterification System
1982 • 130 citations
Levels and interrelationships of serum and lipoprotein cholesterol and triglycerides. Association with adiposity and the consumption of ethanol, tobacco, and beverages containing caffeine.
1981 • 126 citations
Review of lipid-lowering clinical trials in relation to observational epidemiologic studies.
1987 • 126 citations
Uptake of canine beta-very low density lipoproteins by mouse peritoneal macrophages is mediated by a low density lipoprotein receptor.
1986 • 123 citations
Overexpression of Low Density Lipoprotein (LDL) Receptor Eliminates LDL from Plasma in Transgenic Mice
1988 • 121 citations
Regulation of Hepatic Lipoprotein Receptors in the Dog. RAPID REGULATION OF APOLIPOPROTEIN B,E RECEPTORS, BUT NOT OF APOLIPOPROTEIN E RECEPTORS, BY INTESTINAL LIPOPROTEINS AND BILE ACIDS
1983 • 120 citations
Prevention of coronary heart disease--propaganda, promises, problems, and prospects.
1986 • 111 citations
Cholestyramine-induced changes in low density lipoprotein composition and metabolism. I. Studies in the guinea pig.
1985 • 110 citations
Influence of Combined Therapy with Mevinolin and Interruption of Bile-Acid Reabsorption on Low Density Lipoproteins in Heterozygous Familial Hypercholesterolemia
1985 • 108 citations
Increased coronary mortality in relatives of hypercholesterolemic school children: the Muscatine study.
1979 • 103 citations
Drugs and Lipid Metabolism
1973 • 102 citations
Complementarity of Colestipol, Niacin, and Lovastatin in Treatment of Severe Familial Hypercholesterolemia
1987 • 87 citations
Treatment of homozygous familial hypercholesterolaemia with probucol.
1982 • 83 citations
George Lyman Duff memorial lecture. Role of the liver in atherosclerosis.
1985 • 81 citations
Secretion of lipoproteins from the liver of normal and Watanabe heritable hyperlipidemic rabbits.
1983 • 81 citations
Functional Activities of Hepatic Lipoprotein Receptors
1986 • 76 citations
Treatment of Hypercholesterolemia
1982 • 73 citations
Treatment of Hypertriglyceridemia
1984 • 70 citations
Coronary artery atherosclerosis revisited in Korean war combat casualties.
1987 • 61 citations
Effect of low density lipoprotein receptor deficiency on the metabolism of apolipoprotein B-100 in blood plasma. Kinetic studies in normal and Watanabe heritable hyperlipidemic rabbits.
1987 • 56 citations
Role of apolipoprotein E in lipoprotein metabolism
1987 • 42 citations
Mevinolin stimulates receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
1983 • 40 citations
The role of the liver in atherosclerosis.
1950 • 24 citations
Longitudinal serum lipoprotein changes in white males during adolescence: The Bogalusa Heart Study
1985 • 22 citations
Comparison of clofibrate and caloric restriction on kinetics of very low density lipoprotein triglycerides.
1985 • 21 citations
Treatment of Hypercholesterolemia
1986 • 19 citations
Experimental atherosclerosis
1966 • 18 citations
High density lipoprotein alterations induced by bezafibrate in healthy male volunteers
1987 • 15 citations
High risk versus public health strategies in primary prevention of coronary heart disease
1987 • 14 citations
Functional Activities of Hepatic Lipoprotein Receptors
1986 • 9 citations
Dietary regulation of plasma lipoprotein metabolism in humans.
1983 • 5 citations